Delivery Order SPE2DB20D3101-SPE2DB25FRPE7

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,957.10 firm fixed-price contract is for the supply of Naloxone HCL 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a performance period ending on June 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, with no subcontractors mentioned. This contract is not designated as a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4 mg naloxone hydrochloride nasal spray. The contract has a ceiling value of $2,032.50 and a period of performance extending to July 7, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,287.20 and a completion date of February 25, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used to reverse opioid overdoses. The total ceiling value of the contract is $1,315.00, with an ultimate completion date of April 2, 2025. This contract award is not associated with any set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,630.20 and an ultimate completion date of January 30, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,908,804 units of Naloxone HCL 4 mg Nasal Spray 2s, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,437.31 and a completion date of April 15, 2025. It is a firm fixed-price contract with no set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naloxone HCl 4 mg nasal spray, a critical medication used to reverse opioid overdose. The contract has a ceiling value of $3,313.76 and will run through January 29, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Naloxone HCL 4 mg nasal spray, which is used to treat opioid overdoses. The total ceiling value of the contract is $12,453.28, and it runs through April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $4,388.47 and runs through February 2025. There is no set-aside designation, indicating open competition for the award. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,008,836 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a ceiling value of $1,171.34 and a period of performance through April 24, 2025. This award is not set aside for any specific business category. AmerisourceBergen Drug...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRPE7
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naloxone Hydrochloride 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a ceiling value of $3,252.34 and a period of performance through July 3, 2025.

AmerisourceBergen Drug Corp is the prime contractor and there are no major subcontractors noted. The contract is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies.

Generated 10/1/25, 10:06 AM